Demonstration of functional M3-muscarinic receptors in ventricular cardiomyocytes of adult rats

被引:36
作者
Pönicke, K
Heinroth-Hoffmann, I
Brodde, OE
机构
[1] Univ Halle Wittenberg, Inst Pharmacol, D-06097 Halle Saale, Germany
[2] Univ Essen Gesamthsch, Sch Med, Dept Pathophysiol, D-45147 Essen, Germany
[3] Univ Essen Gesamthsch, Sch Med, Dept Nephrol, D-45147 Essen, Germany
关键词
rat cardiomyocytes; inositol phosphates; M-2-receptors; M-3-receptors; carbachol; derifenacin; pertussis toxin;
D O I
10.1038/sj.bjp.0704997
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Muscarinic receptors (M-receptors) in the mammalian heart are predominantly of the M-2-subtype. The aim of this study was to find out whether there might exist an additional myocardial non-M-2-receptor. 2 For this purpose, we assessed, in adult rat isolated ventricular cardiomyocytes, carbachol-induced [H-3]-inositol phosphate (IP) formation, and its inhibition by M-receptor antagonists. 3 Carbachol (10(-7) - 10(-3) mol l(-1)) increased IP-formation (maximal increase: 14+/-3% abode basal, n = 6). This increase was significantly enhanced by pretreatment with pertussis toxin (PTX, 250 ng ml(-1) for 20 h): maximal increase was 31+/-5%, pEC(50)-value was 5.08+/-0.33 (n - 6). 4 In PTX-pretreated cardiomyocytes 100 mumol l(-1) carbachol-induced IP-formation as inhibited by atropine (pK(i)-value: 8.89+/-0.10) and by the M-3-receptor antagonist darifenacin (pK(i)-value: 8.67+/-0.23) but was not significantly affected by the M-1-receptor antagonist pirenzepine (1 mumol l(-1)) or the M-2-receptor antagonists AF-DX 116 and himbacine (1 mumol l(-1)). 5 In conclusion, in adult rat cardiomyocytes there exists an additional, non-M-2-receptor, that is coupled to activation of the phospholipase C/IP3-pathway: this receptor is very likely of the M-3-subtype.
引用
收藏
页码:156 / 160
页数:5
相关论文
共 25 条
[1]  
Brodde OE, 1999, PHARMACOL REV, V51, P651
[2]  
Caulfield MP, 1998, PHARMACOL REV, V50, P279
[3]   Signaling mechanisms underlying muscarinic receptor-mediated increase in contraction rate in cultured heart cells [J].
Colecraft, HM ;
Egamino, JP ;
Sharma, VK ;
Sheu, SS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :32158-32166
[4]   Muscarinic receptors in the mammalian heart [J].
Dhein, S ;
Van Koppen, CJ ;
Brodde, OE .
PHARMACOLOGICAL RESEARCH, 2001, 44 (03) :161-182
[5]   Phenotypic stability of chick cardiomyocytes in serum-free media - Preservation of muscarinic receptor expression [J].
Eatman, D ;
Arthur, TM ;
Ahmed, S ;
Grubbs, RD .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2000, 44 (03) :533-542
[6]   ANALYSIS OF MUSCARINIC CHOLINOCEPTORS MEDIATING PHOSPHOINOSITIDE HYDROLYSIS IN GUINEA-PIG CARDIAC-MUSCLE [J].
FORD, APDW ;
EGLEN, RM ;
WHITING, RL .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 225 (02) :105-112
[7]  
GADBUT AP, 1994, J BIOL CHEM, V269, P25823
[8]   M(1) MUSCARINIC RECEPTORS INCREASE CALCIUM CURRENT AND PHOSPHOINOSITIDE TURNOVER IN GUINEA-PIG VENTRICULAR CARDIOCYTES [J].
GALLO, MP ;
ALLOATTI, G ;
EVA, C ;
OBERTO, A ;
LEVI, RC .
JOURNAL OF PHYSIOLOGY-LONDON, 1993, 471 :41-60
[9]   Muscarinic M3 receptor subtype gene expression in the human heart [J].
Hellgren, I ;
Mustafa, A ;
Riazi, M ;
Suliman, I ;
Sylvén, C ;
Adem, A .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (01) :175-180
[10]   Quantitation of mRNAs for M1 to M5 subtypes of muscarinic receptors in rat heart and brain cortex [J].
Krejcí, A ;
Tucek, S .
MOLECULAR PHARMACOLOGY, 2002, 61 (06) :1267-1272